Most pharmaceutical companies, especially those that require fast, temperature-controlled shipments, use air freight.
At the moment, air transport based on passenger planes has been hit hard: airlines have reduced flights during the COVID-19 pandemic.
Where it is allowed and technically possible, airlines replace passenger flights with cargo flights, and also use charter flights.
All these factors affect the continuous activity of pharmaceutical companies, as well as their financial indicators.
To ensure the continuity of clinical trials, all shippers must continuously check with carriers to maintain flight schedules.
The coronavirus pandemic is changing priorities across a wide range of health care and clinical research issues.
Comments